Tuberculosis (TB) remains a significant global health concern, despite considerable advancements in medical technology. The ability to accurately diagnose TB is critical in controlling its spread and improving patient outcomes. This article provides a comprehensive review of current diagnostic methods for TB.
The traditional TB diagnostic approach primarily involves microscopic examination of sputum samples for acid-fast bacilli, culture techniques, and the tuberculin skin test. However, these methods have limitations, including low sensitivity, delayed results, and potential for false positives.
With the advent of molecular biology, new diagnostic techniques have emerged. Polymerase chain reaction (PCR) based tests, such as Xpert MTB/RIF, offer rapid and accurate detection of TB and rifampicin resistance. Whole genome sequencing (WGS) provides comprehensive information about the TB strain, including drug resistance profiles, but is currently limited by cost and technical complexity.
Interferon-gamma release assays (IGRAs) are blood tests that measure the immune response to TB antigens. IGRAs have improved specificity compared to the tuberculin skin test and can help differentiate between latent and active TB. However, they cannot distinguish between different stages of disease.
Imaging techniques, particularly chest radiography and computed tomography (CT), are often used in conjunction with other diagnostic methods. They can provide valuable information about the extent of disease and potential complications, but cannot definitively diagnose TB.
In conclusion, a combination of traditional, molecular, immunological, and imaging techniques is often required for accurate TB diagnosis. Continued research and development in this field is essential to improve diagnostic accuracy and speed, which will ultimately lead to better patient outcomes and more effective TB control.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation